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Classical (non–T) NK cells are generally found 
at  low  frequencies  in  leukocyte  populations 
(Biron et al., 1999). They have the potential to 
mediate antiviral and immunoregulatory func-
tions through a variety of mechanisms (Orange 
et al., 1995; Su et al., 2001; Lee et al., 2007; 
Robbins et al., 2007; Strowig et al., 2008). By 
altering cell availability, in vivo conditions 
changing NK cell numbers may indirectly in-
fluence all of their effects. Activating receptors 
on NK cells are linked to stimulatory pathways 
overlapping with those used by TCRs to drive 
cell expansions (Murali-Krishna et al., 1998; 
Pitcher et al., 2003; French et al., 2006; Mac-
Farlane and Campbell, 2006; Biron and Sen, 
2007; Lee et al., 2007) and can induce NK cell 
proliferation (Dokun et al., 2001; French et al., 
2006). Although particular activating receptors 
have been reported to recognize microbial 
products (Lanier, 1998; Vidal and Lanier, 2006; 
Jonjic et al., 2008), dramatic NK cell expansion 
has not been observed during infections. Except 
under rare experimental conditions (Caligiuri 
et al., 1991; Yamada et al., 1996; Fehniger et al., 
2001; Huntington et al., 2007a; Sun et al., 2009), 
NK cell division is generally induced for lim-
ited periods of time as a consequence of tran-
sient innate cytokine exposure (Biron et al., 
1984; Biron et al., 1999; Dokun et al., 2001; 
Nguyen et al., 2002; Yokoyama et al., 2004). 
Increasing proportions of NK cell subsets with 
activating receptors recognizing particular viral 
ligands can be detected during certain infections 
(Dokun et al., 2001; Gumá et al., 2006), but this 
is observed without dramatic increases in over-
all NK cell numbers, and many viral infections 
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Natural killer (NK) cells have the potential to deliver both direct antimicrobial effects 
and regulate adaptive immune responses, but NK cell yields have been reported to vary 
greatly during different viral infections. Activating receptors, including the Ly49H mol-
ecule recognizing mouse cytomegalovirus (MCMV), can stimulate NK cell expansion. To 
define Ly49H’s role in supporting NK cell proliferation and maintenance under conditions 
of uncontrolled viral infection, experiments were performed in Ly49h/, perforin 1 
(Prf1)/, and wild-type (wt) B6 mice. NK cell numbers were similar in uninfected mice, 
but relative to responses in MCMV-infected wt mice, NK cell yields declined in the 
absence of Ly49h and increased in the absence of Prf1, with high rates of proliferation 
and Ly49H expression on nearly all cells. The expansion was abolished in mice deficient 
for both Ly49h and Prf1 (Ly49h/Prf1/), and negative consequences for survival were 
revealed. The Ly49H-dependent protection mechanism delivered in the absence of Prf1 
was a result of interleukin 10 production, by the sustained NK cells, to regulate the 
magnitude of CD8 T cell responses. Thus, the studies demonstrate a previously unappreci-
ated critical role for activating receptors in keeping NK cells present during viral infec-
tion to regulate adaptive immune responses.
© 2009 Lee et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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tion of NK cells uniformly expressing Ly49H. The expansion 
was proven to be dependent on Ly49H. During uncontrolled 
infection in the absence of Prf1, Ly49H beneficially pro-
moted effects for survival, because the sustained NK cells 
produced IL-10 to control the magnitude of the CD8 T cell 
response and limit immunopathology. The data suggest that 
Ly49H-dependent cytotoxicity acts to control viral infection 
and NK cell expansion, but that in the absence of the killing 
function, Ly49H promotes a continued NK cell expansion 
critical for supporting life over death because the NK cells are 
available to regulate adaptive immune responses.
RESULTS
Consequences of Ly49H as compared with Prf1 deficiency 
for maintenance of NK cells
NK responses were investigated in wt, Ly49h-deficient (Fodil-
Cornu et al., 2008), and Prf1-deficient B6 mice after infec-
tion with 2,500 PFU MCMV. As expected and in contrast to 
wt mice, high virus replication was consistently observed   
in the absence of Ly49H receptor (Fig. 1 A). Interestingly, 
Ly49h/ mice had decreasing frequencies and numbers of 
NK cells, identified as either CD49b+TCR (Fig. 1, B and C) 
or NK1.1+TCR (Fig. 1, D and E), in spleens. The differ-
ences in Ly49h/ as compared with wt were greater than 
twofold reductions in percentages and fivefold reductions in 
yields on day 5 of infection. The frequencies of cells express-
ing TCR were comparable in wt and Ly49h/ B6 mice 
(Fig. 1 F), indicating a differential decrease of NK cells. Con-
sistent with earlier studies (Tay and Welsh, 1997; Loh et al., 
2005) and similar to Ly49h/ mice (Fig. 1 A), Prf1/ mice 
showed higher viral loads after infection (Fig. 1 G). Surpris-
ingly, however, Prf1/ mice contained higher frequencies, 
25% or fivefold increases, of splenic CD49b+TCR NK 
cells at day 5 as compared with wt mice (Fig. 1 H), and the 
absolute numbers of these NK cells were significantly higher 
(by approximately threefold) than those of wt mice (Fig. 1 I). 
The trends were the same for NK1.1+TCR NK cells (Fig. 1, 
J and K). The proportions of cells expressing TCR were 
comparable in wt and Prf1/ mice (Fig. 1 L), suggesting se-
lective expansion of NK cells. Thus, the absence of Ly49H 
results in conditions failing to sustain NK cells but the ab-
sence of Prf1 results in profound NK cell expansion during 
MCMV infection. Because both Ly49h/ and Prf1/ mice 
had high viral burdens, the changes in NK cell frequencies 
and yields are not simply a consequence of secondary effects 
resulting from high viral replication.
The  higher  proportions  and  numbers  of  NK  cells  in 
Prf1/ as compared with Ly49h/ mice led us to examine 
expression of Ly49H on the CD49b cell subsets. After chal-
lenge with 2,500 PFU MCMV, 30–50% of splenic CD49b 
cells expressed Ly49H in uninfected wt and Prf1/ mice as 
well as in day 1.5, 3, and 5 infected wt mice (Fig. 2 A). In 
contrast, the proportions of CD49b cells expressing Ly49H 
were increasing during infection of Prf1/ mice such that 
>90% expressed Ly49H on day 5. To evaluate the effect of 
challenge dose, infections were initiated with 1,000, 2,000, or 
induce striking reductions in NK cell functions, frequencies, 
and yields (Biron et al., 1999; Tarazona et al., 2002; Lehoux 
et al., 2004; Reed et al., 2004; Azzoni et al., 2005; Vossen   
et al., 2005; Morishima et al., 2006). Thus, particular condi-
tions of viral challenges must result in differential regulation 
of NK cell proportions and numbers, with consequences for 
the delivery of NK cell functions.
An NK cell activating receptor in the mouse is Ly49H 
(Lanier, 1998; Gosselin et al., 1999; Smith et al., 2000; Vidal 
and Lanier, 2006). This molecule recognizes a mouse CMV 
(MCMV) ligand (Arase et al., 2002; Smith et al., 2002), is 
expressed on NK cell subsets in strains of particular genetic 
backgrounds, including C57BL/6 (B6) mice, and is reported 
to be an exclusive marker for the classical NK cell subset 
(Smith et al., 2000). Through an associated molecule, Ly49H 
stimulates using signaling pathways overlapping with those 
used by the TCR (MacFarlane and Campbell, 2006; Biron 
and Sen, 2007). Additional markers for all NK cells include 
CD49b, expressed on other activated cell types (Arase et al., 
2001); NKp46, selectively expressed on classical NK cells 
(Gazit et al., 2006; Walzer et al., 2007a; Walzer et al., 2007b); 
CD122, the IL-2R chain, expressed on all NK cells and ac-
tivated T cells (Huntington et al., 2007b); and NK1.1, exclu-
sively expressed on C57BL6 (B6) NK and NKT cells (Lian 
and Kumar, 2002; MacDonald, 2002; Yokoyama et al., 2004; 
Huntington et al., 2007b). The TCR with associated CD3 
molecules is not expressed on their cell surfaces (Biron et al., 
1999). The mechanisms for NK cell–enhanced resistance to 
MCMV infection are incompletely characterized (Lee et al., 
2007),  but  Ly49H  contributes  to  their  protective  effects 
(Scalzo et al., 1990; Brown et al., 2001; Daniels et al., 2001; 
Lee et al., 2001; Lee et al., 2003). Engagement of the Ly49H 
receptor can lead to killing of target cells (Arase et al., 2002; 
Smith et al., 2002), and the correlation of increases in viral 
burdens resulting from the absence of Ly49H (Scalzo et al., 
1990) as compared with those resulting from defects in cyto-
toxicity functions, such as mutation of the membrane pore-
forming protein perforin 1 (Prf1; Tay and Welsh, 1997; Loh 
et al., 2005; van Dommelen et al., 2006), supports a role for 
Ly49H-dependent killing of virus-infected cells in the deliv-
ery of NK cell antiviral effects. The receptor may have other 
functions associated with its ability to stimulate proliferation, 
however, as the proportions of NK cells expressing Ly49H 
are increased during MCMV infection (Dokun et al., 2001).
The studies presented in this paper were undertaken to 
dissect the proliferative from the cytotoxic functions accessed 
through Ly49H, and to define the contribution of the regula-
tion of NK cell numbers to protection during infection. To 
carry out the work, responses were evaluated, during MCMV 
infections, in wild-type (wt) B6 mice and mice deficient in 
Ly49h (Fodil-Cornu et al., 2008), Prf1 (Kägi et al., 1994), or 
both. As expected, single Ly49h/ and Prf1/ mice had 
profoundly increased viral burdens, but significant differences 
in NK cell expansion were discovered. The NK cell popula-
tions were decreasing in infected Ly49h/ mice, whereas 
infected Prf1/ mice had an unexpected dramatic prolifera-JEM VOL. 206, September 28, 2009 
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5,000 PFU MCMV. The shift to NK cell subsets predomi-
nantly expressing Ly49H was observed under all conditions, 
but the proportions of NK cells increased with increasing 
challenge dose such that 36% of the splenic leukocytes were 
Ly49H+CD49b+ cells on day 5 after infection with 5,000 PFU 
(Fig. 2 B). Thus, the dramatic increases in NK cells expressing 
Ly49H are observed in response to different doses of MCMV, 
but higher doses lead to higher proportions of the cells.
The phenotype of the expanding NK cells was character-
ized further. Several development or activation status markers 
were compared for their expression on CD49b+TCR NK 
cells from wt and Prf1/ mice at day 4 of MCMV infection. 
Consistent with known NK cell lineage markers, NK cells 
from both mice showed high expression of CD122 (IL-2R 
chain), and high expression of the NK cell activation markers 
CD69, CD11b, and CD11c (Fig. 2 C). Interestingly, markers 
thought to be specific for immature NK cells (Kim et al., 
2002; Huntington et al., 2007b) were differentially expressed, 
with CD27 detected on both wt and Prf1/ NK cell popula-
tions and CD51 (integrin V) detected at high levels on NK 
cells from Prf1/ mice. Investigation of other known lym-
phocyte activation markers, Ly6C and CD62L (L-selectin; 
Sinclair et al., 2008), demonstrated an unexpectedly higher 
expression of Ly6C and lower expression of CD62L on NK 
cells from Prf1/ as compared with wt mice. Expression of 
another NK selective cell marker, NKp46, was also exam-
ined, and virtually all of the NKp46+ cells coexpressed Ly49H 
on day 4 in the Prf1/ mice, but only half expressed Ly49H 
under the other conditions. The cells were double positive 
for CD49b and NKp46 under all conditions (Fig. 2 D). Mixed 
populations of NK cells expressing cytoplasmic CD3 have been 
reported, and certain activated T cells can down-regulate 
CD3  expression  while  maintaining  expression  of  markers 
overlapping with NK cells (Lanier, 2007; Stewart et al., 
2007). Because cytoplasmic staining of CD3 can identify such 
T cell populations, experiments were performed to evaluate 
intracellular CD3 expression in the highly expanding NK 
cells. Intracellular CD3 expression was not significantly ex-
pressed in any of the Ly49H-positive cells isolated from wt or 
Prf1/ mice on either day 0 or 4 (Fig. 2 E). Thus, the NK 
cells expanded in the Prf1/ mice are bona fide NK cells but 
enriched in proportions expressing Ly49H.
Proliferation of Ly49H+ NK cells
To measure proliferation of NK cells during infections of wt, 
Ly49h/, and Prf1/ mice, in vivo incorporation of the 
DNA analogue BrdU was analyzed. In wt mice, CD49b+TCR 
Figure 1.  Effects of Ly49h or Prf1 gene deficiency on NK cell 
frequencies and numbers during MCMV infection. (A–L) Virus titers 
in spleens of wt and Ly49h/ (A) or Prf1/ (G) mice were determined 
at days 0, 1.5, 3, and 5 after infection with 2,500 PFU MCMV. Percent-
ages and absolute numbers of CD49b+TCR NK cells in splenic leuko-
cytes isolated from wt and Ly49h/ (B and C) or Prf1/ (H and I) mice 
were measured at the indicated time points. Percentages and absolute 
numbers of NK1.1+TCR NK cells in splenic leukocytes isolated from 
wt and Ly49h/ (D and E) or Prf1/ (J and K) mice were measured at 
the indicated time points. Percentages of TCR+ cells from wt and 
Ly49h/ (F) or Prf1/ (L) mice were measured at the indicated time 
points. Data are presented as means ± SD of three to six mice. Statisti-
cal significances between groups are indicated (*, P < 0.05; **, P < 0.01). 
Results are representative of two independent experiments with at least 
three mice per group. , not detected.
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even more dramatic differences. In Prf1/ mice on day 4, 
>5- and 50-fold increases in the proportions of BrdU+ NK 
cells, respectively, were observed in comparison to wt and 
Ly49h/ mice. The absolute numbers of proliferating NK 
cells in Prf1/ mice were found to be increased similarly and 
showed the greatest difference at day 4 of MCMV infection. 
Hence, in comparison to wt NK cell responses, NK cells have 
reduced BrdU incorporation in the absence of Ly49H but in-
creased incorporation in the absence of Prf1, and these changes 
are accompanied by respective differences in NK cell yields.
Because a severe defect in NK proliferation was observed 
in the absence of Ly49h, and nearly all NK cells in Prf1/ 
NK cell proliferation was increasing with a peak at day 3 of 
MCMV infection when 31% incorporated BrdU during a 2-h 
pulse in vivo (Fig. 3 A). In the case of Ly49h/ mice, NK 
cell proliferation showed a severe defect at day 3. In sharp 
contrast to these two groups, greater and longer BrdU incor-
poration was observed in Prf1/ mice during MCMV infec-
tion (Fig. 3 A). The peak was found at day 4, and at this time, 
the proportion of BrdU+ cells among the NK cells was 2.3-
fold higher than that in wt mice. Because differential NK cell 
proportions (5% in B6, 2% in Ly49h/, and 15% in Prf1/ 
mice) were found at day 4, the frequencies and numbers of 
proliferating NK cells among splenic leukocytes demonstrated 
Figure 2.  Characterization of highly expanded NK cells in Prf1/ mice. (A) Expression of Ly49H and CD49b on splenic leukocytes at days 0, 1.5, 3, 
and 5 after infection of wt and Prf1/ mice with 2,500 PFU MCMV is shown. (B) NK expansion in splenic leukocytes isolated from day 5 MCMV-infected 
wt and Prf1/ mice using 1,000, 2,000, or 5,000 PFU is shown. (C) Histograms show overlays of CD122, CD69, CD11b, CD11c, CD27, CD51, Ly6C, and 
CD62L expressed on gated CD49b+TCR NK cells from day 4 MCMV-infected (2,500 PFU) wt (red line) and Prf1/ (blue line) mice. (D) Dot plots show 
expression of Ly49H and CD49b with regard to NKp46 expression on splenic leukocytes isolated from day 4 MCMV-infected wt and Prf1/ mice. Circles 
indicate the absence of specific populations. (E) Dot plots show expression of intracellular CD3 chain with regard to Ly49H expression on splenic leuko-
cytes isolated from day 4 MCMV-infected wt and Prf1/ mice. The numbers indicate percentages of cells in each area. Results are representative of two 
independent experiments with three mice per group.JEM VOL. 206, September 28, 2009 
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a higher rate than did Ly49H NK cells in wt mice, and these 
cells were absent in Ly49h/ mice. Interestingly, at this time 
point in Prf1/ mice, most NK cells were expressing Ly49H, 
and these NK cells had the highest level of BrdU incorpora-
tion. As analyzed in Fig. 3 B, the frequency of Ly49H NK 
cells incorporating BrdU was similar among B6, Ly49h/, 
and Prf1/ mice, whereas the frequency in Ly49H+ NK cells 
mice were shown to be Ly49H expressing during MCMV 
infection, BrdU incorporation was specifically examined 
within the Ly49H-positive and -negative subsets (Fig. 3 B). 
As the peak of BrdU incorporation in Prf1/ mice and the 
maximum difference in NK proliferation between wt and 
Prf1/ mice were observed at day 4, this time point was 
chosen for the analysis. The Ly49H+ NK cells proliferated at 
Figure 3.  Preferential proliferation of Ly49H+ NK cells in Prf1/ mice during MCMV infection. (A) Percentages of and BrdU incorporation in 
CD49b+TCR NK cells isolated from wt, Ly49h/, and Prf1/ mice on indicated days after infection were measured. Infections were initiated with 
2,500 PFU of virus, and BrdU was administered 2 h before harvest. The proportions of NK cells incorporating BrdU and their numbers in total splenic leu-
kocytes are shown with SD from replicate samples. (B) Dot plots indicate BrdU incorporation in the context of Ly49H expression in NK cells from wt, 
Ly49h/, and Prf1/ mice at days 0 and 4 MCMV after infection. Dot plots gated on the CD49b+CD3 population are shown. The numbers given in the 
top right indicate the percentage of cells in each quadrant. Percentages of BrdU+ cells among Ly49H and Ly49H+ NK cell subsets at day 4 MCMV infec-
tion of wt, Ly49h/, and Prf1/ mice were determined. Data are presented as means ± SD of three to six mice. Statistical significances between groups 
are indicated (*, P < 0.05; **, P < 0.01). Results are representative of two independent experiments with at least three mice per group. , not detected.2240 NK CELL PROLIFERATION FOR REGULATION OF ADAPTIVE IMMUNITY | Lee et al.
To evaluate the consequences of the Ly49H-dependent 
NK cell expansion for health, body weight changes and sur-
vival were evaluated for extended periods of time after infec-
tions in wt, Prf1/, and Ly49h/Prf1/ mice. At a challenge 
dose  of  2,500  PFU  of  virus,  the  wt  mice  started  gaining 
weight at day 4 after infection. In contrast, both the Prf1/ 
and the Ly49h/Prf1/ mice were losing weight by day 4 
of infection. The Prf1/ mice had only 6% weight loss at 
maximum. This was sustained through intermediate times, 
and the mice were returning to their preinfection weights at 
day 12 after infection. However, the Ly49h/Prf1/ mice 
continued losing weight after day 4 and reached weight losses 
of 15% at intermediate times (day 10) before starting to 
then gain weight on day 12 (Fig. 5 A). After infection with 
5,000 PFU MCMV, the wt and Prf1/ mice survived, but 
Ly49h/Prf1/ mice were beginning to die at day 6 and 
80% had succumbed by day 10 of infection (Fig. 5 A). Thus, 
the Ly49h/Prf1/ mice are significantly more sensitive to 
disease during MCMV infection, and the presence of Ly49H 
makes the difference between life and death.
Because the separation of body weight loss and survival 
after day 4 of infection was observed in the Ly49h/Prf1/ 
as compared with wt and Prf1/ mice, viral titers were mea-
sured. As expected, wt mice were clearing a challenge dose of 
2,500 PFU MCMV by day 4 and 5 after infection. In contrast, 
both the Prf1/ and the Ly49h/Prf1/ mice had substan-
tially higher (>4 log) increases in viral titers at these times, but 
the groups did not differ significantly (Fig. 5 B). Thus, differ-
ences in disease susceptibility between the Prf1/ and the 
Ly49h/Prf1/ mice could not be explained by altered sen-
sitivity to infection. Because pathology during viral infections 
can also be a result of the magnitude of immune responses, cir-
culating levels of cytokines were measured on days 4 and 5 of 
infection. wt mice had extremely low levels of IFN- and 
TNF-, whereas both the Prf1/ and the Ly49h/Prf1/ 
mice had elevated levels of these cytokines on days 4 and 5 of 
infection, with no statistically significant differences in TNF- 
but higher IFN- levels on day 5 in the Ly49h/Prf1/ mice 
(Fig. 5 B). The differences in disease parameters in these two 
groups of mice were, however, also accompanied by signifi-
cant differences in circulating levels of IL-10, a cytokine known 
to inhibit T cell responses. Serum IL-10 levels were undetectable 
in wt mice. High circulating levels of the cytokine were detect-
able in the Prf1/ mice; on day 5 of infection, it reached a level 
of >3,600 pg/ml in individual mice. However, Ly49h/ 
Prf1/ mice only had IL-10 levels reaching 984 pg/ml 
(Fig. 5 B). Therefore, under conditions of viral challenge in 
Prf1/ mice, there is high Ly49H-dependent NK cell expan-
sion  and  better  protection  against  disease,  whereas  Prf1/ 
mice also deficient for Ly49H lose their NK cells, have poor 
health, and succumb to death. High endogenous IL-10 pro-
duction is present in the first but not the second condition.
IL-10 production by NK cells
To determine whether or not the expanded NK cells were 
producing IL-10, NK cells were purified and their ex vivo 
was significantly higher in Prf1/ mice. Therefore, preferen-
tial proliferation of Ly49H+ NK cells accompanies the dra-
matic expansion of NK cell numbers in Prf1/ mice.
Although  the  studies  clearly  demonstrated  heightened 
proliferation of Ly49H+ cells, particularly in Prf1/ mice, 
they did not evaluate a potential contribution of cell-intrin-
sic differences to division. To determine the intrinsic prolif-
erative potential of Ly49H+ as compared with Ly49H cells 
from wt, Prf1/, and Ly49h/ mice, negatively enriched NK 
cells (40–50%) were stimulated with a growth factor capable 
of activating all cells, IL-2, and with control cells (BaF3) or 
cells expressing the Ly49H ligand m157 (BaF3/m157) ex vivo. 
The BrdU incorporation was evaluated after a 2-h pulse at 
the end of stimulation. After IL-2 treatment, BrdU incorpo-
ration in NK1.1+TCR NK cells from wt, Ly49h/, and 
Prf1/ mice was comparable and irrespective of Ly49H 
expression (Fig. S1 A). In contrast, stimulation with either 
-irradiated BaF3 or BaF3/m157 cells demonstrated that 
Ly49H+ NK cells from both wt and Prf1/ mice specifically 
incorporated BrdU in response to the ligand and did so at 
comparable rates but that Ly49H cells did not (Fig. S1 B). 
The populations from Ly49h/ mice had extremely poor 
responses under these conditions. The results indicated that 
the intrinsic proliferative responsiveness of NK cells from wt, 
Ly49h/, and Prf1/ mice are equivalent but that the ex-
pression of the Ly49H selects for subset expansion in either 
wt or Prf1/ populations.
Requirement for the Ly49H receptor in sustaining NK cell 
proliferation and survival, and consequences for health
To directly test the hypothesis that the enhanced NK cell 
expansion in Prf1/ mice is dependent on Ly49H, mice de-
ficient in both Prf1 and Ly49h (hereafter Ly49h/Prf1/) 
were bred and investigated for NK cell proliferation at   
day 4 of MCMV infection. As compared with wt mice, the 
Ly49h/Prf1/ and Prf1/ mice were both highly suscep-
tible to MCMV infection, and showed similar levels of un-
controlled virus replication (Fig. 4 A). The ablation of the 
Ly49h gene in Prf1/ mice, however, resulted in dramatic 
reductions of both NK cell frequencies and numbers at day 4 
(Fig. 4, B and C), with the absolute number of NK cells be-
ing lower by greater than two- and fivefold, respectively, as 
compared with wt and Prf1/ mice (Fig. 4 C). The frequen-
cies of cells expressing TCR were comparable among the 
groups (Fig. 4 D). To examine the consequences for prolif-
eration in vivo, experiments were performed with 2-h BrdU 
pulses.  The  NK  cells  were  identified  as  CD49b+TCR 
(Fig. 4 E) and NKp46+TCR (Fig. 4 F) populations. A se-
vere reduction in the percentages of BrdU+ NK cells was ap-
parent in the absence of Ly49H. When examined as total 
numbers of NK cells incorporating, a significant reduction 
(up  to  greater  than  eightfold)  was  observed  in  Ly49h/ 
Prf1/ as compared with Prf1/ mice at day 4 of MCMV 
infection (Fig. 4, G and H). Thus, the Ly49H NK receptor 
is required for NK cell proliferation and maintenance of 
NK cells during MCMV infections in Prf1/ mice.JEM VOL. 206, September 28, 2009 
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ported in Fig. 5 B, the Prf1/ but not the wt mice had high 
circulating levels of IFN- and IL-10 on day 4. Ex vivo pro-
duction of IFN- but not IL-10 was detectable with NK but 
not non–NK cells enriched from the wt mice. High produc-
tion of both of these cytokines, however, was enriched in the 
production of the factor was measured. For these studies, wt 
and Prf1/ mice were infected for 4 d. In the first set of ex-
periments (Fig. 6 A), total, NK and non–NK cells were pre-
pared by positive selection using CD49b+ magnetic bead 
isolation to compare responses in wt and Prf1/ mice. As re-
Figure 4.  Ly49H NK receptor requirement for enhanced NK proliferation in Prf1/ mice. (A) Virus titers in spleen were determined at day 4 
after infection of wt, Prf1/, and Prf1/Ly49h/ mice with 2,500 PFU MCMV. (B–D) Percentages (B) and absolute numbers (C) of CD49b+TCR NK 
cells and percentages (D) of TCR+ cells in splenic leukocytes were determined at days 0 and 4. (E) Percentages of and BrdU incorporation in 
CD49b+TCR NK cells from wt, Prf1/, and Prf1/Ly49h/ mice at day 4 after infection are shown. (F) Percentages of and BrdU incorporation in 
NKp46+TCR NK cells at day 4 after infection are shown. (G and H) The proportions and numbers of proliferating CD49b+TCR NK cells (G) or 
NKp46+TCR NK cells (H) in total splenic leukocytes of wt, Prf1/, and Prf1/Ly49h/ mice at day 4 after infection were determined. Data are pre-
sented as means ± SD of three to six mice. Statistical significances between groups are indicated (*, P < 0.05; **, P < 0.01). Results are representative of 
two independent experiments with at least three mice per group. , not detected.2242 NK CELL PROLIFERATION FOR REGULATION OF ADAPTIVE IMMUNITY | Lee et al.
The cytokine IL-21 has been reported to induce IL-10 
mRNA expression within NK cells (Brady et al., 2004). It 
was not possible to detect IL-21 protein production in the 
serum (unpublished data), but the mRNA was detected using 
samples from the populations isolated on day 4 after infection 
of the Prf1/ mice. The signal was increased in the samples 
prepared from non–NK rather than NK cells (Fig. 6 C). 
Many culture experiments evaluating NK cell responses are 
enhanced by the addition of IL-15, and this cytokine was be-
ing expressed at the mRNA level in samples prepared from 
non–NK as compared with NK cells (Fig. 6 C) on day 4 after 
infection of the Prf1/ mice. To evaluate the pathways stim-
ulating IL-10 on day 4 in the Prf1/ mice, ex vivo production 
NK but not the non–NK cells from the Prf1/ mice. As a 
second approach, highly purified NK cells were prepared 
from the Prf1/ mice by FACS sorting of the CD49b+Ly49H+ 
cells on day 4 of infection (Fig. 6 B). Again, ex vivo produc-
tion of IFN- and IL-10 was greatly enriched in the NK but 
not the non–NK cell populations. The total and sorted popu-
lations from day 4 MCMV-infected Prf1/ mice were also 
examined for IL-10 expression at the mRNA level using 
RT-PCR, and the signaling for IL-10 was increased in the 
NK but not the non–NK cells (Fig. 6 C). Thus, high IL-10 
is being produced in the Prf1/ but not the Ly49h/Prf1/ 
mice at intermediate times after infection, and the greatly ex-
panded NK cells are the source of the factor.
Figure 5.  Ly49H receptor requirements for better protection during infections of Prf1/ mice. (A) Body weight change after infection with 2,500 
PFU MCMV and survival after infection with 5,000 PFU MCMV were evaluated in wt, Prf1/, and Ly49h/Prf1/ mice. Results of body weight changes are 
representative of two independent experiments. Survival data were compiled from two independent experiments, and the p-value was determined by the 
log-rank survival test. (B) Virus titers in spleens, and IFN-, TNF-, and IL-10 levels in serum from wt, Prf1/, and Ly49h/Prf1/ mice after MCMV infec-
tions were measured at indicated time points. Symbols provide results from individual mice (wt, closed diamonds; Prf1/, closed triangles; Ly49h/
Prf1/, open triangles). Horizontal line data presented are means, and vertical lines indicate the ± SD of three to five mice. Statistical significances 
between groups are indicated (**, P < 0.01). Results are representative of at least two independent experiments with at least three mice per group.JEM VOL. 206, September 28, 2009 
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pared with cytokine stimulation. In this case, IL-21 treatment 
alone increased the levels to 3,451 pg/106 cells, and IL-21 
with IL-15 treatment increased the levels to 8,582 pg/106 
cells (Fig. 6 D). Thus, NK cells activated during MCMV in-
fection of Prf1/ mice produce IL-10, and IL-21 is a potent 
inducer of elevated IL-10 production by these cells.
by the total, NK, and non–NK cells was evaluated after stim-
ulation with antibodies against Ly49H or with cytokines. 
Treatment with plate-bound anti-Ly49H did induce increases 
in IL-10 production by the NK cells, with levels increased 
approximately from 230 to 307 pg/106 cells (Fig. 6 D). This 
was an extremely modest response, however, when com-
Figure 6.  IL-10 production by NK cells from MCMV-infected Prf1/ mice. (A) The top dot plots show the purity of NK cells (CD49b+) and non–
NK cells (CD49b) isolated from day 4 MCMV-infected wt and Prf1/ mice after CD49b+ magnetic isolation. The numbers indicate percentages of cells in 
each box. Cytokine production of IFN- and IL-10 in the serum of infected wt and Prf1/ mice, or in 24 h conditioned media prepared with total splenic 
leukocytes and isolated subsets were determined. (B) The top dot plots show purity of NK cells (CD49b+Ly49H+) and non–NK cells (CD49bLy49H) cells 
of day 4 MCMV-infected Prf1/ mice after flow sorting. The numbers indicate percentages of cells in each box. Cytokine production of IFN- and IL-10 
in serum of infected Prf1/ mice, or in 24 h conditioned media from total splenic leukocytes and isolated subsets were determined. (C) Expression of  
IL-10, IL-21, and IL-15 in the total and sorted populations from day 4 MCMV-infected Prf1/ mice was analyzed by semiquantitative RT-PCR. Gapdh was 
used as an internal control. (D) Total splenic leukocytes, highly purified NK, and non–NK subsets from day 4 MCMV-infected Prf1/ mice were stimulated 
either on anti-Ly49H antibody or with cytokines. After 24 h of incubation, IL-10 production was determined in conditioned media. Results are representa-
tive of at least two independent experiments using a total of two to four individual mice. The studies in A were repeated twice for wt and four times for 
Prf1/ mice. Those in B were repeated three times, and those in C were repeated twice. The studies in D with anti-Ly49H antibody were repeated twice, 
and those with cytokines were repeated four times. The dashed white line indicates that intervening lanes have been spliced out. , not detected.2244 NK CELL PROLIFERATION FOR REGULATION OF ADAPTIVE IMMUNITY | Lee et al.
with 5,000 PFU MCMV. The first experiments examined 
the consequences of blocking IL-10 with antibodies against 
the IL-10 receptor (anti–IL-10R). Although all wt mice treated 
with anti–IL-10R survived the infection, Prf1/ mice treated 
Role for Ly49H and IL-10 in regulating CD8 T cell responses
To examine the T cell responses in the wt, Prf1/, and 
Ly49h/Prf1/ mice, mice were infected with MCMV for 
7 d. Although the proportions of NK cells (CD49b+TCR) 
in Prf1/ mice were increased and those in Ly49h/Prf1/ 
mice were severely reduced, the frequencies of CD8+TCR+ 
cells reached 25–30% in all three groups of mice (Fig. 7 A). 
The activation states, however, were higher in the Prf1/ 
mice and highest in the Ly49h/Prf1/ mice. The propor-
tions of CD8 T cells from these mice expressing IFN- were 
<1, 6, and 22%, respectively, and those expressing granzyme 
B were <4, 47, and 71%, respectively. When the proportions 
and yields of CD8+IFN-+ cells in splenic populations were 
calculated,  the  order  and  differences  between  the  groups 
were similar. In terms of overall yields of CD8 T cells ex-
pressing IFN-, however, the Ly49h/Prf1/ mice had 
>45-fold increases as compared with wt mice and >4.2-fold 
increases as compared with Prf1/ mice (Fig. 7 B). The 
MCMV titers were higher in the Ly49h/Prf1/ as com-
pared with the Prf1/ mice, but the difference was not sig-
nificant (Fig. 7 C). In contrast, the circulating levels of IFN-, 
TNF-,  and  IL-10  were  all  substantially  and  significantly   
increased in the Ly49h/Prf1/ mice, with values at least 
3.4-fold higher. Thus, the Ly49h/Prf1/ mice lacking NK 
cell expansion and dramatically reduced NK cell production 
of IL-10 at intermediate times after infection have profoundly 
increased CD8 T cell responses to MCMV infection with 
only modest increases in viral burdens.
IL-10 has a wide range of immunoregulatory functions 
including controlling T cell responses (Maynard and Weaver, 
2008). To examine its role in the regulation of CD8 T cell 
responses in the Prf1/ mice, the consequences of neutraliz-
ing the cytokine were evaluated. Mice were given control 
antibody or antibody-neutralizing IL-10. The treatment pro-
tocol used was developed to deliver maximum effects while 
allowing reappearance of day 7 circulating levels of IL-10 
equivalent to those in the Prf1/ mice, i.e., concentrations 
of 200–300 mg/ml (Fig. 7 C, bottom right). It required anti-
body delivery on days 2 and 4 of infection (see Materials and 
methods). Both control and anti–IL-10 antibody groups of 
mice still had increasing proportions of NK cells (CD49b+ 
TCR; Fig. 8 A). They were very different, however, in 
their CD8 T cell responses. Neutralization of IL-10 resulted 
in elevated endogenous CD8 T cell responses (Fig. 8, A and B). 
In this case, the viral burdens were increased by 1.5 logs, 
and this difference was significant (Fig. 8 C). The circulating 
levels of IFN-, TNF-, and IL-10 were, however, increased 
by 12.6-, 10-, and 5.5-fold, respectively (Fig. 8 C). Overall, 
the differences in the parameters examined after IL-10 neu-
tralization during MCMV infection of Prf1/ mice paral-
leled those observed in the Ly49h/Prf1/ mice. Therefore, 
early IL-10 production by the Ly49H-sustained NK cells 
regulates CD8 T cell responses.
To examine IL-10’s role in controlling detrimental effects 
during infections in the Prf1/ mice, the effects of IL-10 
neutralization were evaluated under conditions of infection 
Figure 7.  Effect of Ly49H on CD8 T cell responses in MCMV- 
infected Prf1/ mice. (A) Splenic leukocytes from day 0 and 7 MCMV-
infected wt, Prf1/, and Ly49h/Prf1/ mice were analyzed for 
frequencies of NK cells and CD8 T cells, and expression of IFN- and 
granzyme B in CD8 T cells. (B) Percentages and absolute numbers of 
CD8+IFN-+ in total splenic leukocytes isolated from day 0 and 7 
MCMV-infected wt, Prf1/, and Ly49h/Prf1/ mice were determined. 
(C) Virus titers in spleens, and IFN-, TNF-, and IL-10 in serum samples 
from day 0 and 7 MCMV-infected wt, Prf1/, and Ly49h/Prf1/ mice 
were measured. The numbers indicate the percentages of cells in each 
area. Data are presented as means ± SD of three to six mice. Statistical 
significances between groups are indicated (*, P < 0.05; **, P < 0.01).  
Results are representative of at least two independent experiments with 
at least three mice per group. , not detected.JEM VOL. 206, September 28, 2009 
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with anti–IL-10R all died by day 11 of infection (unpub-
lished data). As an independent approach, Prf1/ mice were 
treated with control antibody or antibody against the cyto-
kine itself (IL-10) on days 2 and 4 of infection, as described 
in the previous paragraph. Administration of IL-10 resulted 
in death of >80% of the Prf1/ mice (Fig. 8 D). Thus, block-
ing early IL-10 effects in Prf1/ results in a increased sensi-
tivity to infection and a phenotype comparable to Ly49h/ 
Prf1/ mice.
Role for CD8 T cell responses in late cytokine responses  
and death during infections of Ly49h/Prf1/ mice
To conclusively demonstrate the contribution of the CD8 T 
cell response to cytokine production and death after MCMV 
challenge in the Ly49h/Prf1/ mice, mice were control 
treated or treated with antibodies against CD8 (CD8). After 
challenge with 2,500 PFU of virus, blocking the CD8 T cell 
response had no effect on the day 7 viral titers in the Ly49h/ 
Prf1/ mice (Fig. 9 A) but did significantly inhibit the ele-
vated circulating levels of cytokines (Fig. 9 A). Moreover, the 
CD8 treatment protected against the lethal consequences 
of infection with 5,000 PFU MCMV (Fig. 9 B). Thus, the 
presence of the CD8 T cell responses was not effective at 
controlling the viral infection but did result in elevated cyto-
kine responses and death. Collectively, the studies demon-
strate that expanded NK cells and early IL-10 production is 
regulating  the  magnitude  of  endogenous  CD8  T  cell  re-
sponses and protecting from a CD8 T cell–dependent death 
under these conditions of sustained viral infections.
DISCUSSION
These studies demonstrate an unexpected role for an activat-
ing receptor in sustaining NK cells and, as a result, protecting 
against detrimental consequences during viral infection. In 
particular, they define the Ly49H receptor’s contribution to 
the proliferation and maintenance of NK cells during MCMV 
infections. In wt B6 mice, viral replication was controlled. 
NK cell proliferation peaked at day 3 after challenge, with 
the proportions of Ly49H+ populations increasing without 
profound cell expansion. Deficiencies in Ly49h, Prf1, or both 
all resulted in significant increases in MCMV burdens, but 
the consequences for NK cell expansion were profoundly 
Figure 8.  Effect of blocking of IL-10 on CD8 T cell responses in 
and survival of MCMV-infected Prf1/ mice. (A) Splenic leukocytes 
from day 0 and 7 MCMV-infected Prf1/ mice treated with either con-
trol antibody or anti–IL-10 antibody were analyzed for frequencies of NK 
cells and CD8 T cells, and expression of IFN- and granzyme B in CD8 T 
cells. (B) Percentages and absolute numbers of CD8+IFN-+ in total 
splenic leukocytes from day 0 and 7 MCMV-infected Prf1/ mice treated 
with either control antibody or anti–IL-10 antibody are shown. (C) Virus 
titers in spleens, and IFN-, TNF-, and IL-10 levels in serum samples 
from day 0 and 7 MCMV-infected Prf1/ mice treated with either con-
trol antibody or anti–IL-10 antibody were measured. The numbers indicate 
the percentages of cells in each area. Data are presented as means ± SD 
of three to six mice. Statistical significances between groups are indicated 
(**, P < 0.01). Results are representative of at least two independent ex-
periments with at least three mice per group. (D) Survivals of Prf1/ 
mice infected with 5,000 PFU and treated with either control antibody or 
anti–IL-10 antibody were evaluated. Data were compiled from two inde-
pendent experiments, and the p-value was determined by the log-rank 
survival test. , not detected.
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NK cells expressed Ly49H, (b) the Ly49H+ cells were pref-
erentially proliferating, and (c) ablation of the Ly49h gene in 
addition to the Prf1 gene (Ly49h/Prf1/) abolished NK 
cell proliferation. The Ly49H-dependent effects were im-
portant because the absence of Ly49h in the Prf1/ mice 
resulted in increased sensitivity to disease and death. The 
expanded Ly49H+ NK cells in Prf1/ mice were making 
IL-10, and CD8 T cell responses were being regulated by the 
NK cells and IL-10; CD8 T cell responses were dramatically 
elevated in Ly49h/Prf1/ and Prf1/ mice having had 
IL-10 function neutralized. Elevated CD8 T cell responses in 
the Ly49h/Prf1/ mice were responsible for death after 
MCMV challenge. Thus, the Ly49H activating receptor 
contributes to the proliferation and maintenance of NK cells, 
the NK cells are induced to produce IL-10 under these con-
ditions, and the NK cells and IL-10 are important for limit-
ing the magnitude of CD8 T cell responses to make the 
difference between life and death (Fig. 10).
The results have a broad significance to our understand-
ing of the regulation and function of NK cells during viral 
infections. Before the clear demonstration of a role for NK 
cells in defense against herpes group viruses, there were nu-
merous reports of defects in NK cell functions after a wide 
range of viral infections (Biron et al., 1999; Lee et al., 2007). 
More recently, decreases in NK cell numbers and maturation 
states have been reported during infections of humans with 
HIV (Tarazona et al., 2002; Azzoni et al., 2005), hepatitis C 
virus (HCV; Morishima et al., 2006), and varicella zoster vi-
rus (Vossen et al., 2005); of monkeys with Ebola virus (Reed 
et al., 2004); and of mice with mouse hepatitis virus 3 (Lehoux 
et al., 2004). It is important to note, however, that there are 
genetic differences between individuals and strains, and that 
there are also reports of increases in proportions of NK cells 
expressing particular activating receptors during viral infec-
tions (Dokun et al., 2001; Gumá et al., 2006; De Maria et al., 
2007; Alter et al., 2009). In our study, an activating receptor 
is shown to play a critical role in sustaining NK cells. In fact, 
the extreme expansion of these “MCMV-specific” NK cells 
in the absence of cytotoxic function is demonstrated. Ana-
logues of Ly49H recognition of virus-infected cells have been 
proposed to exist for viruses in humans. One good candidate 
identified during human CMV (HCMV) infections is the 
NKG2C/CD94-activating NK receptor. Significantly increased 
proportions of NK cells expressing NKG2C are observed in 
HCMV seropositive individuals compared with HCMV se-
ronegative individuals (Gumá et al., 2006). Increases in the 
proportions of NK cells expressing the NKp30 activating re-
ceptor have been observed during chronic HCV infection 
(De Maria et al., 2007), and in the proportions of NK cells 
expressing the KIR3DS1 activating receptor have been ob-
served during acute HIV infection (Alter et al., 2009). Thus, 
studies in both mice and men indicate that activating recep-
tors may be helping to select NK cell subsets during infec-
tions and that as a consequence, the frequencies of NK cells 
expressing particular activating receptors are changing. Our 
study also demonstrates, however, that activating receptors 
different; NK cell proportions, numbers, and division were 
decreased in the absence of Ly49h but dramatically increased 
in the absence of Prf1. The Ly49H receptor was required for 
the responses in infected Prf1/ mice because (a) nearly all 
Figure 9.  Effect of blocking CD8 T cell responses during MCMV 
infection of Ly49h/Prf1/ mice. (A) Virus titers in spleens, and IFN-, 
TNF-, and IL-10 levels in serum samples from day 0 and 7 MCMV-infected 
Ly49h/Prf1/ mice treated with either control antibody or anti-CD8 
antibody were measured. Symbols provide results from individual mice. 
Horizontal line data presented are means, and the vertical lines indicate  
± SD of five mice. Statistical significances between groups are indicated  
(*, P < 0.05; **, P < 0.01). Results are representative of at least two indepen-
dent experiments. (B) Survivals of Ly49h/Prf1/ mice MCMV infected 
with 5,000 PFU and treated with either control antibody or anti-CD8 
antibody were evaluated. Data were compiled from two independent ex-
periments, and the p-value was determined by the log-rank survival test.JEM VOL. 206, September 28, 2009 
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enhance IL-10 production, mRNA expression of IL-21 is 
also apparent, and addition of this cytokine causes dramatic 
(>15-fold) increases in IL-10 production by the NK cells. 
Thus, the system demonstrates a mechanism using the acti-
vating NK cell receptor to promote the continued presence 
of the cells for activation by other cytokines. Keeping the 
cells around is likely to enhance resistance and health under 
a wide range of viral infections, and learning how to manage 
this during infections failing to directly stimulate an activat-
ing receptor to support NK cell expansion will have impor-
tant therapeutic applications.
The cytokine IL-10 was first shown to be a product of T 
cells, but the list of cellular sources is growing (Brooks et al., 
2006; Ejrnaes et al., 2006; Maris et al., 2007; O’Garra and 
Vieira, 2007). Before our study, the characterization of NK 
cell IL-10 production had been largely limited to expression at 
the mRNA level during Toxoplasma infection of mice (Maroof 
et al., 2008), after treatment of mouse cells with IL-21 (Brady 
et al., 2004), or in cells prepared from HIV-infected indi-
viduals (Brockman et al., 2009). There are recent reports, 
however, that human regulatory NK cells can be mitogen 
stimulated to produce IL-10 (Deniz et al., 2008) and that NK 
cells recovered during chronic HCV infections produce IL-10 
(De Maria et al., 2007). Although the factor can also enhance 
inflammatory responses under particular conditions (Herrero 
are required for sustaining NK cells because the absence of 
Ly49H results in decreasing NK cell yields during MCMV 
infections. Collectively, the studies show that activating re-
ceptors promote the expansion of particular NK cell subsets 
and that without such a pathway, NK cells are not sustained 
during prolonged infection.
The work adds to the growing literature characterizing 
conditions supporting NK cell expansion (Biron et al., 1984; 
Caligiuri et al., 1991; Yamada et al., 1996; Lanier, 1998; Biron 
et al., 1999; Dokun et al., 2001; Fehniger et al., 2001; 
Nguyen et al., 2002; Yokoyama et al., 2004; French et al., 
2006; Huntington et al., 2007a; Sun et al., 2009). In this case, 
the importance for the expansion is clearly demonstrated. 
Keeping the NK cells around is likely to promote defense 
and immunoregulatory mechanisms mediated through the 
activating receptor supporting expansion, and allow access of 
those induced through stimulation of other activating recep-
tors, cytokine receptors, and/or engagement of the TNF- 
related apoptosis-inducing ligand expressed on activated NK 
cells (Lee et al., 2007). The latter three mechanisms have the 
potential to promote effects even if stimulation of the origi-
nal activating receptor through its ligand is blocked. The NK 
cells expanded in the Prf1/ mice during MCMV infection 
are shown in this paper to be producing IL-10. Although 
stimulation through Ly49H itself could modestly (<1.5-fold) 
Figure 10.  Model for sustaining NK cells for regulation of adaptive immune responses during viral infections. (A) In the absence of stimulation 
through activating receptors, NK cells decrease during extended viral infections. As a result, they are not available to contribute antiviral and/or immune 
regulatory functions for extended periods. If the virus is unchecked, unregulated downstream adaptive immune responses can lead to immune pathology 
and death. (B) In the presence of stimulation through activating receptors, NK cell proliferation is supported and the cells are available to contribute a 
wide range of functions for extended periods. The studies in this paper demonstrate that during profound viral infections, the conditions can result in 
induction of NK cell IL-10 production to regulate the magnitude of adaptive CD8 T cell responses and protect from CD8 T cell–dependent death.2248 NK CELL PROLIFERATION FOR REGULATION OF ADAPTIVE IMMUNITY | Lee et al.
recognition of LCMV. Thus, LCMV infections of Prf1/ mice 
may present a condition where NK cells are not expanded for 
maintenance, and as a result, they are not available to critically 
contribute to the regulation of the CD8 T cell response. This 
model would explain the dramatic magnitude of CD8 T cell 
responses during LCMV infections of both wt and Prf1/ 
mice (Matloubian et al., 1999), as well as the apparent major 
contribution of the CD8 T cell responses to hemophagocytic 
lymphohistocytosis diseases under conditions of LCMV (Jordan 
et al., 2004) but not MCMV (Crozat et al., 2007) infections in 
systems with blocked cytotoxic functions. The model also sug-
gests that the balance of NK and CD8 T cell responses might 
be controlled in a wide range of infection by the presence or 
absence of a ligand for an NK cell activating receptor.
In summary, this paper discovers a novel and important 
new pathway for sustaining NK cells during infection, proves 
its critical role in protection against disease, and defines the 
mechanism for the beneficial effects dependent on this path-
way as NK cell regulation of adaptive immunity.
MATERIALS AND METHODS
Mice. Specific pathogen-free C57BL/6 (C57BL/6NTac) mice were pur-
chased from Taconic. Ly49h-deficient (Ly49h/) mice with a B6 back-
ground were generated by a marker-assisted congenic approach (Fodil-Cornu 
et al., 2008). Perforin-deficient (Prf1/) mice (Kagi et al., 1994) were origi-
nally obtained from the Jackson Laboratory to establish breeding colonies at 
Brown University. Mice deficient in both Ly49h and Prf1 (Ly49h/Prf1/) 
were generated by crossing Ly49h/ and Prf1/ mice. All mouse colonies 
were kept and maintained in strict isolation under specific pathogen-free 
conditions. Mice used in experiments were 6–14 wk old. Animals obtained 
from sources outside of Brown University were housed in the animal care 
facility for at least 1 wk before use. Handling of mice and experimental pro-
cedures were conducted in accordance with institutional guidelines for ani-
mal care and use, and protocols were approved by the Brown University 
Institutional Animal Care and Use Committee.
In vivo manipulation. Unless otherwise indicated in the figures, infections 
were initiated on day 0 by i.p. injection of 2,500 PFU of salivary gland– 
derived MCMV prepared, as previously described (Orange et al., 1995; 
Dalod et al., 2002). Experiments were repeated with independently derived 
Smith strain MCMV from American Type Culture Collection, as previously 
described (Depatie et al., 1997). The infectious virus in tissue homogenates 
was quantified by plaque assay using mouse embryonic fibroblasts (Orange   
et al., 1995). To evaluate in vivo DNA synthesis, mice were injected with   
2 mg BrdU (BD) on the days indicated in the figures and sacrificed 2 h later. 
For CD8 T cell blocking, 1 mg anti-CD8 antibody (clone 53.6.72; Bio-
Express) was administered by i.p. injection at day 5. For controls, an equal 
amount of rat IgG (Sigma-Aldrich) was given. For blocking of the IL-10 re-
ceptor,  500  µg  of  blocking  anti–IL-10R  antibody  (clone  1B1.3A;  Bio- 
Express) was administered by i.p. injection at day 3. For neutralization of IL-10, 
600 µg anti–IL-10 antibody (clone JES5-2A5; Bio-Express) was adminis-
tered by i.p. injection at days 2 and 4. An equal amount of isotype control 
rat IgG1 mAb (clone HRPN; Bio-Express) was used as a control for anti– 
IL-10R antibody and anti–IL-10 antibody. The anti–IL-10 protocol was 
developed by modifying treatment conditions to maximize effects, ensure 
neutralization of the IL-10 produced at intermediate times after infection, 
and allow circulating levels of the cytokine on day 7. For the survival assay, 
mice were infected with 5,000 PFU MCMV.
Preparation of leukocyte populations. For preparation of splenic leuko-
cytes, spleens were ground between the rough surfaces of glass slides and 
treated with Red Blood Cell Lysing Buffer (Sigma-Aldrich) to remove red 
et al., 2003; Sharif et al., 2004), IL-10 has largely been appre-
ciated for its direct and indirect inhibitory effects on several T 
cell  responses  (Deniz  et  al.,  2008;  Maynard  and  Weaver, 
2008). Therefore, the production of IL-10 during infections 
has been thought to present a situation for interfering with vi-
ral defense (Brooks et al., 2006; Ejrnaes et al., 2006; De Maria 
et al., 2007; Maris et al., 2007). However, IL-10 has also been 
shown  to  contribute  to  regulation  of  immunopathology 
(Gazzinelli et al., 1996), and the expansion of NK cells and 
their early production of IL-10 reported in this paper is dem-
onstrated to be important for limiting CD8 T cell response 
and CD8 T cell–dependent disease. Thus, an NK cell contri-
bution to regulating adaptive immunity for protection against 
immune-mediated disease is demonstrated for the first time. 
The pathway may be in place at some level during infections 
of immunocompetent mice because our laboratory has previ-
ously shown NK cell–dependent regulation of T cell responses 
to MCMV in wt mice (Su et al., 2001), and challenges with 
extremely high doses of the virus have been reported to in-
duce low levels of IL-10 and IL-10–dependent protection 
against disease (Oakley et al., 2008).
The work also conclusively separates, for the first time, 
the beneficial functions of Ly49H-dependent expansion from 
Ly49H-dependent cytotoxicity. The activating receptor has 
been reported to induce NK cell killing and proliferation 
in culture, but only delivery of cytotoxic function has been 
thought to be important in protection against MCMV (Scalzo 
et al., 1990; Tay and Welsh, 1997; Loh et al., 2005; van 
Dommelen et al., 2006). Although other factors such as cyto-
kines may contribute (Nguyen et al., 2002; French et al., 
2006), the requirement for Ly49H in supporting NK cell pro-
liferation and health are definitively established in the absence 
of cytotoxic function. The results suggest a model whereby 
NK cells are sustained during periods of intense receptor stim-
ulation but delivery of cytotoxic function to regulate viral rep-
lication acts to limit expansion by eliminating virus-infected 
cells. In the absence of cytotoxicity or in the presence of over-
whelming viral replication failing to be limited by cytoxicity, 
however, NK cell expansion is increased through an Ly49H-
dependent pathway to promote alternative beneficial effects. 
This identification of the importance of the activating receptor 
in the context of infection is distinct from another report in-
vestigating the role of these molecules in NK cell maturation 
and tolerance (Sun and Lanier, 2008; Tripathy et al., 2008). In 
this study, the activating receptor is shown to be critical for 
maintaining NK cells during acute infectious challenge.
Given these results, it is interesting to consider CD8 T cell 
expansion during infections with lymphocytic choriomeningi-
tis virus (LCMV), a virus inducing dramatic expansion of CD8 
T cells in Prf1/ mice (Matloubian et al., 1999). Collectively, 
the  responses  to  MCMV  and  LCMV  indicate  that  linking 
stimulation for killing with stimulation for proliferation may be 
important for regulating proportions of both NK and CD8 T 
cells. It is remarkable, however, that in contrast to the known 
MCMV expression of a ligand for the NK cell activating recep-
tor Ly49H, there is no evidence for NK cell activating receptor JEM VOL. 206, September 28, 2009 
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5-CATATGCTCGAGGGACGTGTTGATGAACAT-3;  Zhang  et  al., 
1998). Gapdh (forward, 5-ACCACAGTCCATGCCATCAC-3; reverse, 
5-TCCACCACCCTGTTGCTGTA-3) was used as an internal control. 
The data shown in the figures were obtained before the amplification prod-
ucts reached saturation.
Evaluation of the body weight and survival. Mice were weighed and 
monitored for death once a day at the same time on every day during infec-
tion from day 0 (before infection) to day 16. For clarity, body weight changes 
at 2-d intervals are shown in the figures.
Statistical analyses. Statistical analyses were performed using an unpaired 
Student’s two-tailed t test. Means ± SD are shown. The Kaplan-Meier log-
rank test was used to compare survival between groups of mice using Prism 5 
software (GraphPad Software, Inc.).
Ex vivo NK cell proliferation assay. For evaluation of intrinsic prolifera-
tive activity of NK cells, NK cells were enriched (30–50% of NK1.1+TCR 
cells) from splenocytes of wt, Ly49h/, and Prf1/ mice using negative se-
lection with magnetic beads (Miltenyi Biotec). 5 × 104 enriched NK cells 
were stimulated on 96-well plates with either 150 ng/ml IL-2 or -irradiated 
Ba/F3 cells and Ba/F3 cells expressing m157 (effector/target ratio = 2:1; a gift 
from L. Lanier, University of California, San Francisco, San Francisco, CA). 
At 40 h after stimulation, cells were incubated with BrdU at a 20-µM concen-
tration for an additional 2 h and were analyzed for BrdU incorporation.
Online supplemental material. Fig. S1 shows intrinsic NK cell prolifera-
tive potentials. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20082387/DC1.
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